HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

Abstract
Skeletal muscle atrophy occurs in many chronic diseases and disuse conditions. Its severity reduces patient recovery, independence and quality of life. The discovery of two muscle-specific E3 ubiquitin ligases, MAFbx/atrogin-1 and Muscle RING Finger-1 (MuRF1), promoted an expectation of these molecules as targets for therapeutic development. While numerous studies have determined the conditions in which MAFbx/atrogin-1 and MuRF1 mRNA levels are regulated, few studies have investigated their functional role in skeletal muscle. Recently, studies identifying new target substrates for MAFbx/atrogin-1 and MuRF1, outside of their response to the initiation of muscle atrophy, suggest that there is more to these proteins than previously appreciated. This review will highlight our present knowledge of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy, the impact of potential therapeutics and their known regulators and substrates. Finally, we will comment on new approaches that may expand our knowledge of these two molecules in their control of skeletal muscle function.
AuthorsVictoria C Foletta, Lloyd J White, Amy E Larsen, Bertrand Léger, Aaron P Russell
JournalPflugers Archiv : European journal of physiology (Pflugers Arch) Vol. 461 Issue 3 Pg. 325-35 (Mar 2011) ISSN: 1432-2013 [Electronic] Germany
PMID21221630 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Muscle Proteins
  • Tripartite Motif Proteins
  • Fbxo32 protein, mouse
  • SKP Cullin F-Box Protein Ligases
  • TRIM63 protein, human
  • Ubiquitin-Protein Ligases
Topics
  • Acquired Immunodeficiency Syndrome (physiopathology)
  • Aging (physiology)
  • Animals
  • Cachexia (physiopathology)
  • Denervation
  • Diabetes Mellitus (physiopathology)
  • Fasting (physiology)
  • Humans
  • Immobilization (adverse effects)
  • Muscle Proteins (physiology)
  • Muscular Atrophy (metabolism)
  • Pulmonary Disease, Chronic Obstructive (physiopathology)
  • Renal Insufficiency (physiopathology)
  • SKP Cullin F-Box Protein Ligases (physiology)
  • Sepsis (physiopathology)
  • Spinal Cord Injuries (physiopathology)
  • Tripartite Motif Proteins
  • Ubiquitin-Protein Ligases (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: